Il Dong Pharmaceutical Co Ltd (249420) - Total Liabilities

Latest as of September 2025: ₩347.04 Billion KRW ≈ $235.18 Million USD

Based on the latest financial reports, Il Dong Pharmaceutical Co Ltd (249420) has total liabilities worth ₩347.04 Billion KRW (≈ $235.18 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Il Dong Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Il Dong Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Il Dong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Il Dong Pharmaceutical Co Ltd asset portfolio.

Il Dong Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Il Dong Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Edda Wind ASA OL:EWIND	Norway	Nkr395.75 Million
HD Renewable Energy Co. Ltd. TW:6873	Taiwan	NT$9.25 Billion
Braskem SA Class A NYSE:BAK	USA	$90.97 Billion
India Nippon Electricals Limited NSE:INDNIPPON	India	Rs2.46 Billion
Total Bangun Persada Tbk JK:TOTL	Indonesia	Rp2.97 Trillion
Sun Tekstil Sanayi ve Ticaret A.S. IS:SUNTK	Turkey	TL5.63 Billion
Kis Wire KO:002240	Korea	₩686.56 Billion
Drugs Made In America Acquisition Corp. Units NASDAQ:DMAAU	USA	$7.28 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Il Dong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 249420 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Il Dong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Il Dong Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Il Dong Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩429.99 Billion ≈ $291.39 Million	-1.60%
2023-12-31	₩437.00 Billion ≈ $296.15 Million	-4.50%
2022-12-31	₩457.59 Billion ≈ $310.10 Million	-16.56%
2021-12-31	₩548.39 Billion ≈ $371.63 Million	+56.36%
2020-12-31	₩350.73 Billion ≈ $237.68 Million	-2.53%
2019-12-31	₩359.83 Billion ≈ $243.85 Million	+25.01%
2018-12-31	₩287.84 Billion ≈ $195.07 Million	+2.97%
2017-12-31	₩279.55 Billion ≈ $189.45 Million	-0.85%
2016-12-31	₩281.94 Billion ≈ $191.07 Million	--

About Il Dong Pharmaceutical Co Ltd

KO:249420 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$308.76 Million

₩455.61 Billion KRW

Market Cap Rank

#14784 Global

#471 in Korea

Share Price

₩14460.00

Change (1 day)

+0.28%

52-Week Range

₩12150.00 - ₩44300.00

All Time High

₩75500.00